GlobeNewswire - News from Massachusetts

Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering

Fri, 05 Feb 2021 02:49 GMT

BOSTON, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced the pricing of its public offering of 5,000,000 shares of its common stock at a public offering price of?$30.00 per share. All of the shares are being offered by Rhythm. In addition, Rhythm has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of its common stock at the public offering price, less the underwriting discount and commission. The offering is expected to close on?February 9, 2021, subject to the satisfaction of customary closing conditions.

New High-Performance Rugged Server Bolsters Cybersecurity for Multi-Domain Operations

Thu, 04 Feb 2021 21:35 GMT

Delivers data center-level performance while maintaining data integrity at the edge

Delivers data center-level performance while maintaining data integrity at the edge

Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning Competition

Thu, 04 Feb 2021 21:30 GMT

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc.?(NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the four winners of the Rare Lessons lesson planning competition. Sarepta has granted the winning authors $2,500 each and $2,500 to the educational institution with which each is affiliated. The winning submissions are now available on sharemylesson.com, and more information about the authors can be found at Sarepta.com/rarelessons.

ARIA Cybersecurity Solutions Launches ARIA CloudADR Offering

Thu, 04 Feb 2021 21:15 GMT

A Cloud-based, virtual AI-SOC for automated threat detection and response

A Cloud-based, virtual AI-SOC for automated threat detection and response

Relay Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 2021 Oncology Day

Thu, 04 Feb 2021 21:05 GMT

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in a fireside chat at the Guggenheim Healthcare Talks 2021 Oncology Day on Thursday, February 11, 2021 at 3:30 p.m. ET. The fireside chat will be webcast live and may be accessed from the Investor page of Relay’s website under Events and Presentations. Within 24 hours following the fireside chat, an archived replay of the webcast will be available for up to one year.

Genocea to Host Fourth Quarter 2020 Corporate Update Conference Call & Webcast

Thu, 04 Feb 2021 21:05 GMT

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, will host its fourth quarter 2020 financial results and corporate update conference call and live audio webcast on?Thursday, February 11th?at 8:30 a.m. ET.

T2 Biosystems T2SARS-CoV-2? Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus

Thu, 04 Feb 2021 21:05 GMT

Panel is capable of detecting 99.99% of all currently identified SARS-CoV-2 viruses based on sequence alignments and in silico analysis

LPL Financial Announces Fourth Quarter and Full Year 2020 Results

Thu, 04 Feb 2021 21:05 GMT

Fourth Quarter 2020 Key Financial Results

LAWSUIT FILED: Penumbra, Inc. Sued for Violations of the Federal Securities Laws; Investors Should Contact Block & Leviton LLP

Thu, 04 Feb 2021 21:00 GMT

BOSTON, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Nationally-recognized securities law firm Block & Leviton LLP (www.blockleviton.com) announces that a lawsuit for violation of the federal securities laws has been filed against Penumbra, Inc. (NYSE: PEN) and certain of its executives.

Discover the Future of Small Scale Sterile Filling in this Free Webinar Series

Thu, 04 Feb 2021 19:15 GMT

13 experts from six industry leading companies developed a comprehensive guide to the newest technologies in sterile manufacturing to improve flexibility, processing speed, and sterility assurance.

13 experts from six industry leading companies developed a comprehensive guide to the newest technologies in sterile manufacturing to improve flexibility, processing speed, and sterility assurance.

E&I Cooperative Services & PaymentWorks Announce New Agreement for Secure Vendor Management

Thu, 04 Feb 2021 18:43 GMT

WALTHAM, Mass. and JERICHO, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- PaymentWorks and E&I Cooperative Services (E&I) recently launched a competitively solicited lead public agency (LPA) contract for supplier information management (SIM) systems. This agreement creates an avenue for E&I members in higher education and K-12 to implement secure, repeatable, transparent vendor onboarding and relationship management.

MultiBrush by Rendever Now Available on SideQuest, Providing Artists with a Collaborative Tool in Virtual Reality

Thu, 04 Feb 2021 18:30 GMT

Rendever’s CTO, Tom Neumann, was the first to develop a working multiplayer form of Tilt Brush, all in an effort to connect community members together

Rendever’s CTO, Tom Neumann, was the first to develop a working multiplayer form of Tilt Brush, all in an effort to connect community members together

EyePoint Pharmaceuticals Announces Closing of $115 Million Public Offering of Common Stock

Thu, 04 Feb 2021 17:29 GMT

WATERTOWN, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced the closing of an underwritten public offering of 10,465,000 shares of its common stock at a public offering price of $11.00 per share, including the exercise in full by the underwriters of their option to purchase up to 1,365,000 additional shares of common stock. The gross proceeds of the offering to the Company are approximately $115.1 million, before deducting the underwriting discounts and commissions and other estimated offering expenses.

Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide

Thu, 04 Feb 2021 16:35 GMT

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany, (Multimmune) on October 1^st, 2020, for its clinical stage autologous Natural Killer (“NK”) cell therapy and companion diagnostic platform, for all fields worldwide.

Bridgeline Digital Announces $2.7 Million Registered Direct Offering

Thu, 04 Feb 2021 14:25 GMT

WOBURN, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of cloud-based Marketing Technology software, announced today a registered direct offering of 880,000 shares of its common stock (the “Offering”) at a price to the public of $3.10 per share, for gross proceeds of approximately $2.7 million prior to deduction of commissions and offering expenses payable by Bridgeline. The lead investors for the Offering include those certain of the Special Situations Funds and other institutional investors.

Biogen Announces Cash Tender Offer?for 5.200% Senior Notes Due 2045?Open to Certain Holders Only

Thu, 04 Feb 2021 14:02 GMT

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the commencement of an offer to purchase for cash (the “Cash Offer”) any and all of its outstanding 5.200% Senior Notes due 2045 (the “Notes”), totaling $1.75 billion in aggregate principal amount, on the terms and conditions set forth in the Offer to Purchase dated February 4, 2021 (the “Offer to Purchase”) and the accompanying certification of eligibility to participate in the Cash Offer, the instructions for such certification and the notice of guaranteed delivery (collectively, the “Cash Offer Documents”). No consents to any amendment or waiver of the terms of the indenture governing the Notes are being solicited in connection with the Cash Offer.

DocuSign Joins Duck Creek Partner Ecosystem to Digitally Transform Producer Onboarding and Contracting

Thu, 04 Feb 2021 14:00 GMT

Boston, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Duck Creek Technologies announced today that it has expanded its Partner Ecosystem program through a new relationship with DocuSign, which offers the world's #1 e-signature solution as part of the DocuSign Agreement Cloud. An integration between Duck Creek Distribution Management and DocuSign eSignature enables insurance carriers to enhance producer experiences and create operational efficiencies.

Adform Names Semcasting AudienceDesigner (ADS) as Key Partner for First-Party Data Onboarding

Thu, 04 Feb 2021 14:00 GMT

NORTH ANDOVER, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Semcasting, creators of the patented IP, location and device-targeting Smart Zones? technology, today announced its AudienceDesigner (ADS) platform was named a key partner for first-party data onboarding by Adform, one of the world's leading independent advertising technology companies.

Biogen Announces Private Exchange Offer for 5.200% Senior Notes Due 2045 Open to Certain Investors

Thu, 04 Feb 2021 14:00 GMT

CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the commencement of a private offer to exchange (the “Exchange Offer”) any and all of its outstanding 5.200% Senior Notes due 2045 (the “Old Notes”), totaling $1.75 billion in aggregate principal amount, for a new series of senior notes to be issued by Biogen (the “New Notes”) and cash, if any, on the terms and conditions set forth in the Offering Memorandum dated February 4, 2021 (the “Offering Memorandum”) and the accompanying eligibility letter (the “Eligibility Letter”), Canadian beneficial holder form and notice of guaranteed delivery (collectively, the “Exchange Offer Documents”). No consents to any amendment or waiver of the terms of the indenture governing the Old Notes are being solicited in connection with the Exchange Offer.

Over 3 Million Copies of the ‘First’ Versions of Avid’s Creative Tools Have Now Been Downloaded by Video and Music Makers

Thu, 04 Feb 2021 14:00 GMT

Success of Avid’s freemium software offering continues to accelerate with record influx of aspiring content creators obtaining free entry-level First versions of the same tools used by celebrated music, film and TV professionals

Success of Avid’s freemium software offering continues to accelerate with record influx of aspiring content creators obtaining free entry-level First versions of the same tools used by celebrated music, film and TV professionals